Alnylam Pharmaceuticals (ALNY) Assets Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.78% |
| Dec 31, 2025 | 11.88% |
| Sep 30, 2025 | 11.13% |
| Jun 30, 2025 | 11.09% |
| Mar 31, 2025 | 7.06% |
| Dec 31, 2024 | 5.19% |
| Sep 30, 2024 | 6.59% |
| Jun 30, 2024 | 4.54% |
| Mar 31, 2024 | 5.52% |
| Dec 31, 2023 | 3.98% |
| Sep 30, 2023 | 5.10% |
| Jun 30, 2023 | 0.28% |
| Mar 31, 2023 | 14.16% |
| Dec 31, 2022 | 13.98% |
| Sep 30, 2022 | 11.63% |
| Jun 30, 2022 | 7.03% |
| Mar 31, 2022 | 19.46% |
| Dec 31, 2021 | 32.26% |
| Sep 30, 2021 | 27.49% |
| Jun 30, 2021 | 25.17% |
| Mar 31, 2021 | 19.18% |
| Dec 31, 2020 | 19.54% |
| Sep 30, 2020 | 34.53% |
| Jun 30, 2020 | 33.00% |
| Mar 31, 2020 | 26.21% |
| Dec 31, 2019 | 23.78% |
| Sep 30, 2019 | 24.63% |
| Jun 30, 2019 | 25.26% |
| Mar 31, 2019 | 15.21% |
| Dec 31, 2018 | 4.34% |
| Sep 30, 2018 | 5.28% |
| Jun 30, 2018 | 5.34% |
| Mar 31, 2018 | 5.69% |
| Dec 31, 2017 | 22.71% |
| Sep 30, 2017 | 11.25% |
| Jun 30, 2017 | 11.57% |
| Mar 31, 2017 | 1.63% |
| Dec 31, 2016 | 44.27% |
| Sep 30, 2016 | 43.16% |
| Jun 30, 2016 | 44.03% |
| Mar 31, 2016 | 40.82% |
| Dec 31, 2015 | 68.95% |
| Sep 30, 2015 | 64.55% |
| Jun 30, 2015 | 68.76% |
| Mar 31, 2015 | 68.53% |
| Dec 31, 2014 | 56.45% |
| Sep 30, 2014 | 47.05% |
| Jun 30, 2014 | 44.70% |
| Mar 31, 2014 | 43.05% |
| Dec 31, 2013 | 2.26% |
| Sep 30, 2013 | 2.74% |
| Jun 30, 2013 | 1.67% |
| Dec 31, 2012 | -15.78% |